Assessment of awareness of pre-exposure prophylaxis methods against HIV infection among healthcare specialists, medical students, and charitable foundation volunteers


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To assess awareness of pre-exposure prophylaxis (PrEP) against HIV infection among healthcare specialists, medical students, and charitable foundation volunteers. Subjects and methods. The investigation involved respondents of 3 groups. Group 1 consisted of 73 healthcare workers; Group 2 included 75 five- and six-year medical students of faculties of pediatrics, general medicine, and medicine; Group 3 comprised of 26 volunteers of the «Shagi» (Steps) Regional Charitable Public AIDS Control Foundation. All the groups underwent a survey using the continuous sampling on the days of both face-to-face and Internet surveys. Results. The mean HIV PrEP awareness self-assessment score was 5.36 in Group 1, 4.88 in Group 2, and 5.69 in Group 3. Group 1 respondents mainly received information about the method from scientific literature, in the learning process, and from the Internet (25.9, 22.2, and 12.9, respectively). Group 2 respondents did this in the process of learning, from the Internet, from scientific literature (42.4, 32.2, and 15.3%, respectively). The charitable foundation employees did this in the process of learning, from the Internet, from scientific literature (46,2, 36,6, and 15,4%, respectively). Respondents in this group mentioned PrEP more often when answering an indicator question about the HIV transmission prevention methods known to them (p < 0.05). Conclusion. Poor self-awareness among the surveyed medical professionals, medical students, and non-profit organization employees is one of the main barriers to PrEP method use.

Full Text

Restricted Access

About the authors

Ulyana A. Kuimova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: ulyanakuimova@gmail.com
Cand. Med. Sci., Researcher, Central Research Institute of Epidemiology

Valentina V. Belyaeva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: labora-et-ora@yandex.ru
МD, Leading Researcher

Nadezhda V. Kozyrina

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: nad-kozyrina@yandex.ru
Cand. Med. Sci., Senior Researcher

Ekaterina I. Kulabukhova

Peoples' Friendship University of Russia

Email: ekulabukhova@mail.ru
Cand. Med. Sci., Infectiologist

Marina D. Goliusova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: mad2501@yandex.ru
Infectiologist, Central Research Institute of Epidemiology

Irina V. Kuimova

Novosibirsk State Medical University

Email: kuimova_ira@mail.ru
МD, Professor, Department of Infectious Diseases

References

  1. Holmes D. FDA paves the way for pre-exposure HIV prophylaxis. Lancet 2012; 380: 325.
  2. Hodges-Mameletzis I., Dalal S., Msimanga-Radebe B., Rodolph M., Baggaley R. Going global: the adoption of the World Health Organization’s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health 2018; 15(6): 489-500. doi: 10.1071/SH18125
  3. Anderson P., Glidden D.V., Liu A., Buchbinder S., Lama J.R., Cuaniro J. et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci. Transl. Med. 2012; 4(151): 151ra125. doi: 10.1126/scitranslmed.3004006
  4. Molina J.M., Capitant С., Spire B., Pialoux G., Chidiac C., Charreau I. et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. CROI 2015. 2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015), 23-26 February 2015. Seattle, Washington, USA. Oral late breaker abstract 23LB. http://www.croiconference.org/sessions/demand-prep-oral-tdf-ftc-msm-results-anrs-ipergay-trial
  5. PrEP for HIV Prevention in the U.S. https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/PrEP-for-hiv-prevention-in-the-US-factsheet.html
  6. FDA NEWS RELEASE. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention
  7. Ефремова О.С., Беляева В.В., Козырина Н.В., Куимова У.А., Покровская А.В., Суворова З.К. Оценка информированности ВИЧ-инфицированных пациентов о методике доконтактной профилактики, отношения к ее проведению и перспектив проведения в России. Эпидемиол. инфекц. болезни. Актуал. вопр. 2020; 10(3): 99-104. https://dx.doi.org/10.18565/epidem.2020.10.3.99-104
  8. Беляева В.В., Козырина Н.В., Куимова У.А., Голиусова М.Д., Ефремова О.С. Профилактика передачи ВИЧвдискордантных парах: информированность, осознание риска, поведение. Инфекционные болезни: новости, мнения, обучение 2021; 10(1): 46-51. https://doi.org/10.33029/2305-3496-2021-10-1-46-51

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies